SEER Cancer Statistics Review 1975-2016 National Cancer Institute Joinpoint Regression Program Version 4.7, February 2019, National Cancer Institute. (https://surveillance.cancer.gov/joinpoint/). The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130). a Trends are from the SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, and Atlanta). b Trends are from the SEER 21 areas (SEER 9 areas, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, Georgia excluding ATL/RG, Idaho, New York and Massachusetts). c Trends are from US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention. d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint. e API - Asian/Pacific Islander, AI/AN - American Indian/Alaska Native, NH - Non-Hispanic f Hispanic and Non-Hispanic are not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives. Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registry. g Data for American Indian/Alaska Native are based on the Purchased/Referred Care Delivery Area (PRCDA) counties. * The APC/AAPC is significantly different from zero (p<.05). - Joinpoint regression line analysis could not be performed on data series. JP Trend 1 JP Trend 2 JP Trend 3 JP Trend 4 JP Trend 5 JP Trend 6 AAPC d Years APC Years APC Years APC Years APC Years APC Years APC 2007-16 2012-16 SEER 9 Delay-Adjusted Incidence a , 1975-2016 All Races 1975-82 2.5* 1982-91 1.0* 1991-07 -0.7* 2007-16 -2.1* -2.1* -2.1* White 1975-82 2.6* 1982-91 1.1* 1991-07 -0.6* 2007-16 -2.1* -2.1* -2.1* Black 1975-84 3.5* 1984-03 -0.6* 2003-16 -2.4* -2.4* -2.4* SEER 21 Delay-Adjusted Incidence b , 2000-2016 All Races 2000-08 -0.8* 2008-16 -2.2* -2.1* -2.2* White 2000-08 -0.7* 2008-16 -2.2* -2.0* -2.2* White NH ef 2000-07 -0.4* 2007-16 -1.9* -1.9* -1.9* Black 2000-09 -1.2* 2009-16 -2.6* -2.3* -2.6* Black NH ef 2000-09 -1.1* 2009-16 -2.6* -2.3* -2.6* API e 2000-16 -0.8* -0.8* -0.8* AI/AN eg 2000-16 -1.3* -1.3* -1.3* Hispanic f 2000-08 -0.7* 2008-16 -2.2* -2.0* -2.2* U.S. Cancer Mortality c , 1975-2016 All Races 1975-80 3.0* 1980-90 1.8* 1990-95 -0.2 1995-05 -1.0* 2005-12 -2.3* 2012-16 -3.7* -2.9* -3.7* White 1975-80 2.9* 1980-90 1.8* 1990-95 -0.1 1995-05 -0.8* 2005-12 -2.2* 2012-16 -3.6* -2.8* -3.6* Black 1975-81 3.5* 1981-90 1.9* 1990-95 -0.7* 1995-04 -1.7* 2004-13 -2.7* 2013-16 -5.0* -3.5* -4.4* U.S. Cancer Mortality c , 2000-2016 All Races 2000-05 -1.1* 2005-10 -2.2* 2010-14 -2.8* 2014-16 -4.5* -3.0* -3.7* White 2000-05 -1.0* 2005-10 -2.0* 2010-14 -2.7* 2014-16 -4.3* -2.9* -3.5* White NH ef 2000-05 -0.8* 2005-10 -1.9* 2010-14 -2.6* 2014-16 -4.2* -2.7* -3.4* Black 2000-04 -1.6* 2004-13 -2.7* 2013-16 -5.0* -3.5* -4.4* Black NH ef 2000-04 -1.5* 2004-13 -2.6* 2013-16 -5.0* -3.4* -4.4* API e 2000-11 -1.2* 2011-16 -2.6* -1.9* -2.6* AI/AN eg 2000-16 -1.4* -1.4* -1.4* Hispanic f 2000-16 -2.3* -2.3* -2.3* Table 15.1 Cancer of the Lung and Bronchus (Invasive) Trends in SEER Incidence ab and U.S. Mortality c Using the Joinpoint Regression Program, 1975-2016 With up to Five Joinpoints, 2000-2016 With up to Three Joinpoints, Both Sexes by Race/Ethnicity
37
Embed
SEER Cancer Statistics Review 1975-2016SEER Cancer Statistics Review 1975-2016 National Cancer Institute Joinpoint Regression Program Version 4.7, February 2019, National Cancer Institute.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Joinpoint Regression Program Version 47 February 2019 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding
SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
Black NHef 2000-04 -15 2004-13 -26 2013-16 -50 -34 -44
APIe 2000-11 -12 2011-16 -26 -19 -26
AIANeg 2000-16 -14 -14 -14
Hispanicf 2000-16 -23 -23 -23
Table 151
Cancer of the Lung and Bronchus (Invasive)
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program
1975-2016 With up to Five Joinpoints 2000-2016 With up to Three Joinpoints
Both Sexes by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Joinpoint Regression Program Version 47 February 2019 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding
SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program
1975-2016 With up to Five Joinpoints 2000-2016 With up to Three Joinpoints
Males by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Joinpoint Regression Program Version 47 February 2019 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding
SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program
1975-2016 With up to Five Joinpoints 2000-2016 With up to Three Joinpoints
Females by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Joinpoint Regression Program Version 47 February 2019 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052
c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program
1975-2016 With up to Five Joinpoints
By Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 155Cancer of the Lung and Bronchus (Invasive)
Delay-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Joinpoint Regression Program Version 47 February 2019 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding
SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program
1975-2016 With up to Five Joinpoints 2000-2016 With up to Three Joinpoints
Males by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Joinpoint Regression Program Version 47 February 2019 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding
SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program
1975-2016 With up to Five Joinpoints 2000-2016 With up to Three Joinpoints
Females by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Joinpoint Regression Program Version 47 February 2019 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052
c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program
1975-2016 With up to Five Joinpoints
By Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 155Cancer of the Lung and Bronchus (Invasive)
Delay-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Joinpoint Regression Program Version 47 February 2019 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)b Trends are from the SEER 21 areas (SEER 9 areas Los Angeles Alaska Native Registry Rural Georgia California excluding
SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York and Massachusetts)c Trends are from US Mortality Files National Center for Health Statistics Centers for Disease Control and Preventiond The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpointe API - AsianPacific Islander AIAN - American IndianAlaska Native NH - Non-Hispanicf Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska
Natives Incidence data for Hispanics and Non-Hispanics are based on NHIA and exclude cases from the Alaska Native Registryg Data for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) counties The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
Trends in SEER Incidenceab and US Mortalityc Using the Joinpoint Regression Program
1975-2016 With up to Five Joinpoints 2000-2016 With up to Three Joinpoints
Females by RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Joinpoint Regression Program Version 47 February 2019 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052
c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program
1975-2016 With up to Five Joinpoints
By Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 155Cancer of the Lung and Bronchus (Invasive)
Delay-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Joinpoint Regression Program Version 47 February 2019 National Cancer Institute (httpssurveillancecancergovjoinpoint)The APC is the Annual Percent Change based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-8052
c Trends are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)d The AAPC is the Average Annual Percent Change and is based on the APCs calculated by Joinpoint The APCAAPC is significantly different from zero (plt05)- Joinpoint regression line analysis could not be performed on data series
Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
Trends in SEER 9 Observed Incidencec Using the Joinpoint Regression Program
1975-2016 With up to Five Joinpoints
By Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 155Cancer of the Lung and Bronchus (Invasive)
Delay-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Reference Cancer Incidence Rates Adjusted for Reporting DelayIndividual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Delay-adjusted rate is not shown for observed rates based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 155Cancer of the Lung and Bronchus (Invasive)
Delay-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Reviewa SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 156Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 157Small Cell Cancer of the Lung and Bronchus (Invasive)
Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 80468050-8052 8070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-82418243-8246 8249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 85508560 8562 8570-8572 8574-8576Individual rates for diagnosis years 1975-1979 available in web browser version of Cancer Statistics Review
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 158Non-Small Cell Cancer of the Lung and Bronchus (Invasive)Age-adjusted SEER Incidencea Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Individual rates for years of death 1975-1979 available in web browser version of Cancer Statistics Reviewa US Mortality Files National Center for Health Statistics Centers for Disease Control and Prevention
Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 159Cancer of the Lung and Bronchus (Invasive)
Age-adjusted US Deatha Rates by Year Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
b US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) unless noted
c Rates are per 100000 and are age-adjusted to the world (WHO 2000-2025) standard million- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1510Cancer of the Lung and Bronchus (Invasive)
SEER Incidencea and US Deathb Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045b Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046
c SEER 21 areas Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)unless noted
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Small Cell Cancer of the Lung and Bronchusa Age at DiagnosisAge-Adjusted Rates 2012-2016All ages 61 66 58 67 70 65 49 58 43Under 65 22 22 22 24 24 25 19 21 1865 and over 332 372 305 363 393 342 254 310 218
Table 1511Small Cell Cancer of the Lung and Bronchusa(Invasive) and Non-Small Cell Cancer of the Lung and Bronchusb(Invasive)
SEER Incidencec Rates Age-Adjusted and Age-Specific Rates by Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on End Results data from a series of hospital registries and one population-based registryb SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesc SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
d Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
e Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundingf The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)g The standard error is between 5 and 10 percentage pointsh The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1512Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Small Cell Cancer of the Lung and Bronchus includes histologies 8002 8041-8045a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)
Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tablesb SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-Monterey
Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1513Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Note Non-Small Cell Cancer of the Lung and Bronchus includes histologies 8003-8004 8012-8015 8021-8022 8030-8035 8046 8050-80528070-8076 8078 8082-8084 8090 8094 8120 8123 8140-8141 8143-8145 8147 8190 8200-8201 8211 8240-8241 8243-82468249-8255 8260 8290 8310 8320 8323 8333 8401 843084408470-84718480-8481 8490 8503 8507 8525 8550 8560 85628570-8572 8574-8576
a SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Based on follow-up of patients into 2016 Expected survival rates are derived from the US Annual Life Tables
b SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey andGeorgia excluding ATLRG) Expected survival rates are derived from life tables by socio-economic status geography and racedeveloped by the SEER programBased on follow-up of patients into 2016
c Period survival provides a 2015 estimate of survival by piecing together the most recent conditional survival estimatesfrom several cohorts It is computed here using three year calendar blocks (2010-2012 0-1 year survival)(2009-2011 1-2 year survival) (2008-2010 2-3 year survival) (2007-2009 3-4 year survival) (2006-2008 4-5 years survival)
d Stage at diagnosis is classified using SEER Summary Stage 2000 Stage distribution percentages may not sum to 100 due to roundinge The difference between 1975-1977 and 2009-2015 is statistically significant (plt05)f The standard error is between 5 and 10 percentage pointsg The standard error is greater than 10 percentage points- Statistic could not be calculated due to fewer than 25 cases during the time period
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1514Non-Small Cell Cancer of the Lung and Bronchus (Invasive)
5-Year Relative and Period Survival (Percent) by Race Sex Diagnosis Year Stage and Age
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1515Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males and Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1516Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Males
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Based on the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta)Expected survival rates are derived from the US Annual Life Tables
Table 1517Cancer of the Lung and Bronchus (Invasive)
SEERa Relative Survival (Percent)By Year of Diagnosis
All Races Females
Year of Diagnosis
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 634 497 Asian 0 000 000 001 541 406
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Both Sexes 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 670 549 Asian 0 000 000 001 657 502
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Males 2014-2016 By RaceEthnicity
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Devcan 677 April 2019 National Cancer Institute (httpssurveillancecancergovdevcan)Source Incidence data are from the SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta
San Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts) Mortality data are from the NCHS public use data file for the total US
a Underlying incidence and mortality data for American IndianAlaska Native are based on the PRCDA(PurchasedReferred Care DeliveryAreas) counties
b Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska NativesUnderlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registry
- Statistic could not be calculatedA percent of 000 represents a value that is below 0005
Risk of Being Risk of Being
Race Current Diagnosed with Cancer Risk of Dying Race Current Diagnosed with Cancer Risk of Dying
Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer Ethnicity Age +10 yrs +20 yrs +30 yrs Ever from Cancer
All Races 0 000 000 001 605 450 Asian 0 000 000 001 446 330
Risk of Being Diagnosed With Cancer in 10 20 and 30 Years
Lifetime Risk of Being Diagnosed with Cancer Given Alive and Cancer-Free at Current Age and
Lifetime Risk of Dying from Cancer Given Alive at Current Age
Females 2014-2016 By RaceEthnicity
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
The AAPC is the Average Annual Percent Change over the time interval The AAPCs are calculated bythe Joinpoint Regression Program Version 47 February 2019 National Cancer Institute
- Statistic not shown Rate based on less than 16 cases for the time intervalTrend based on less than 10 cases for at least one year within the time interval
a Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130) Trendsare based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico SeattleUtah and AtlantaThe SEER 21 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the AlaskaNative Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts
c The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 3 Joinpoints overdiagnosis years 2000-2016
d The 2007-2016 AAPC estimates are based on a Joinpoint analysis with up to 5 Joinpoints overdiagnosis years 1975-2016
e Hispanic and Non-Hispanic are not mutually exclusive from whites blacks AsianPacificIslanders and American IndiansAlaska Natives Incidence data for Hispanics and Non-Hispanicsare based on NHIA and exclude cases from the Alaska Native Registry
f Incidence data for American IndianAlaska Native are based on the PurchasedReferred CareDelivery Area (PRCDA) counties
g US Mortality Files National Center for Health Statistics CDCh The 2007-2016 mortality AAPCs are based on a Joinpoint analysis using years of death 2000-2016 The APC is significantly different from zero (plt05)
SEER Incidence and US MortalityAge-Adjusted Rates and Trendsa
By RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and Atlanta
The SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Table 1522Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Incidence Ratesa
By Registry Race and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control and PreventionRates are per 100000 and are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130)
b The SEER 9 areas are San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah and AtlantaThe SEER 13 areas comprise the SEER 9 areas plus San Jose-Monterey Los Angeles the Alaska Native Registry and Rural GeorgiaThe SEER 18 areas comprise the SEER 13 areas plus California excluding SFSJMLA Kentucky Louisiana New Jersey and Georgiaexcluding ATLRGThe SEER 21 areas comprise the SEER 18 areas plus Idaho New York and Massachusetts
- Statistic not shown Rate based on less than 16 cases for the time interval
All Races Whites Blacks Total Males Females Total Males Females Total Males Females
Total US 4186 5164 3436 4265 5171 3564 4435 6211 3235
Table 1523Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted SEER Death Ratesa
By Registry Race and Sex
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 4186 005
High Five StatesKentucky 6613 051 01(0101) 5798c
Arkansas 5747 057 02(0205) 3731c
West Virginia 5699 068 03(0205) 3616c
Mississippi 5646 058 04(0205) 3489c
Tennessee 5586 038 05(0305) 3344c
Low Five StatesCalifornia 3080 013 47(4749) -2642c
Hawaii 3062 060 48(4650) -2685c
New Mexico 2996 050 49(4750) -2842c
Colorado 2931 034 50(4850) -2999c
Utah 1918 041 51(5151) -5418c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1524Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males and Females
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 5164 008
High Five StatesKentucky 8455 088 01(0101) 6373c
Mississippi 7859 106 02(0203) 5219c
Arkansas 7570 098 03(0205) 4658c
Tennessee 7331 067 04(0306) 4195c
West Virginia 7253 115 05(0306) 4045c
Low Five StatesWyoming 3721 162 47(4250) -2795c
California 3647 021 48(4749) -2939c
New Mexico 3522 081 49(4750) -3180c
Colorado 3252 054 50(4950) -3703c
Utah 2345 067 51(5151) -5460c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1525Cancer of the Lung and Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Males
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
a US Mortality Files National Center for Health Statistics Centers for Disease Control andPrevention Rates are per 100000 and are age-adjusted to the 2000 US Std Population (19age groups - Census P25-1130)
b Difference between state rate and total US rate is statistically significant (plt=0002)c Absolute percent difference between state rate and total US rate is 5 or mored Rank of state level death rate and the 95 confidence intervals (low high) for the rankSE Standard error of the ratePD Percent difference between state rate and total US rate- Statistic not shown Rate based on less than 16 cases for the time interval
State Rate SE Rank(CI)d PD TOTAL US 3436 006
High Five StatesKentucky 5222 061 01(0101) 5196c
West Virginia 4505 083 02(0206) 3111c
Oklahoma 4339 061 03(0208) 2627c
Missouri 4318 047 04(0208) 2566c
Arkansas 4303 067 05(0210) 2523c
Low Five StatesColorado 2686 044 47(4649) -2184c
California 2649 016 48(4749) -2293c
New Mexico 2579 063 49(4750) -2494c
Hawaii 2379 072 50(4950) -3078c
Utah 1565 050 51(5151) -5447c
State Rate SE Rank(CI)d PD State Rate SE Rank(CI)d PD
Table 1526Cancer of the Lung And Bronchus (Invasive)
Age-Adjusted Cancer Deatha Rates By State All Races 2012-2016
Females
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
a US 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 Areas (excluding the AlaskaNative Registry) and 112016 US population estimates based on the average of 2015 and 2016 population estimates from theUS Bureau of the CensusPrevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years
b Maximum limited-duration prevalence is 24 years for 1992-2016 datac Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groupsd Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et al 1997
Merrill et al 2000)e Complete prevalence is obtained by summing 0 to lt24 and gt=24- Statistic not shown Statistic based on fewer than 5 cases estimated alive in SEER for the time interval+ Not available
Years Since Diagnosis 0 to lt5 5 to lt10 10 to lt15 15 to lt20 20 to lt24 0 to lt24b gt=24d Completee
Race Sex All Races Both Sexes 296258 106837 52045 27542 12276 494958 43284 538243
Table 1527Cancer of the Lung And Bronchus (Invasive)
Estimated United States Cancer Prevalence Countsa on January 1 2016By RaceEthnicity Sex and Years Since Diagnosis
Estimated prevalence percenta on January 1 2016 of the SEER population diagnosed in the previous 24 yearsBy Age at Prevalence RaceEthnicity and Sex
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Both Sexes by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Males by Race
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
Source SEER 21 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New JerseyGeorgia excluding ATLRG Idaho New York and Massachusetts)Percents may not sum to 100 due to rounding
a Excludes Kaposi Sarcoma mesothelioma lymphomas leukemias myelomas lymphoreticular and immunoproliferative diseasesb Estimates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesc Hispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives
Underlying incidence data for Hispanics are based on NHIA and exclude cases from the Alaska Native Registryd Squamous and transitional cell includes histologies 8051-8052 8070-8076 8078 8083-8084 8090 8094 8120 8123e Adenocarcinoma includes histologies 8015 8050 8140-8141 8143-8145 8147 8190 8201 8211 8250-8255 8260 8290 8310
8320 8323 8333 8401 8440 8470-8471 8480-8481 8490 8503 8507 8550 8570-8572 8574 8576f Large cell includes histologies 8012-8014 8021 8034 8082g Non-small cell carcinoma includes histology 8046h Other specified carcinomas includes histologies 8003-8004 8022 8030 8031-8033 8035 8200 8240-8241 8243-8246 8249 8430
8525 8560 8562 8575i Carcinoma NOS includes histologies 8000-8001 8010-8011 8020 8230j Sarcoma includes histologies 8680 8711 8800-8805 8810-8811 8815 8824 8830 8840 8852 8855 8890-8891 8894-8895
k Other specific types includes melanomas and is defined as histologies 8580 8650 8720-8790 8933 8963 8972-8973 8980-89829064-9065 9070 9080 9084-9085 9100 9260 9364 9503 9530
Note For this analysis the following histolgies were classified as metastases of another primary site and not included 8005 81308146 8170 8231 8247 8263 8312 8340-8341 8350 8441 8460 8500-8501 8524 8530 8551 8581 8585 8710 8772 88068850 8854 8896 8935 9015 9042 9071 9101 9181 9370 9500 9561 9581
- Statistic not shown due to fewer than 16 cases during the time period
AsianPacific American IndianAll Races White Black Islander Alaska Nativeb Hispanicc
Percent Distribution and Counts by Histology among Histologically Confirmed Cases 2012-2016Females by Race
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
0
30
60
90
120
150
180
1975 1985 1995 2005 20160
30
60
90
120
150
180
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus by Race and Sex
a
Figure 151
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
0
20
40
60
80
100
1975 1985 1995 2005 20160
20
40
60
80
100
1975 1985 1995 2005 20160
20
40
60
80
100
1975 1985 1995 2005 20160
20
40
60
80
100
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Under 65 Years of Age by Race and Sex
a
Figure 152
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
0
100
200
300
400
500
600
700
800
1975 1985 1995 2005 20160
100
200
300
400
500
600
700
800
1975 1985 1995 2005 20160
100
200
300
400
1975 1985 1995 2005 20160
100
200
300
400
1975 1985 1995 2005 2016
Delay-Adj IncidenceDelay-Adj Incidence
Observed IncidenceObserved Incidence
MortalityMortality
SEER Observed Incidence SEER Delay Adjusted Incidence and US Death RatesCancer of the Lung and Bronchus Ages 65 and Over by Race and Sex
a
Figure 153
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines and APCs are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer InstituteThe APC is the Annual Percent Change for the regression line segments The APC shown on the graph is for the most recent trendThe APC is significantly different from zero (p lt 005)
a
White Male Black Male White Female Black FemaleRate per 100000 Rate per 100000 Rate per 100000 Rate per 100000
Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath Year of DiagnosisDeath
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
Joinpoint Analyses for Whites and Blacks from 1975-2016and for AsianPacific Islanders American IndiansAlaska Natives and Hispanics from 2000-2016
0
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 20160
10
20
30
40
50
60
70
80
90
100
1975 1985 1995 2005 2016
White
Black
API
AIAN
Hispanic
SEER Incidence and US Death RatesCancer of the Lung and Bronchus Both Sexes
Figure 154
Source Incidence data for whites and blacks are from the SEER 9 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah Atlanta)Incidence data for AsianPacific Islanders American IndiansAlaska Natives and Hispanics are from the SEER 21 areas (SEER 9 areas San Jose-MontereyLos Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLA Kentucky Louisiana New Jersey Georgia excluding ATLRG Idaho New York andMassachusetts)Mortality data are from US Mortality Files National Center for Health Statistics CDCRates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019 National Cancer Institute Joinpoint analyses for Whites andBlacks during the 1975-2016 period allow a maximum of 5 joinpoints Analyses for other ethnic groups during the period 2000-2016 allow a maximum of 3 joinpointsAPI = AsianPacific IslanderAIAN = American IndianAlaska Native Rates for American IndianAlaska Native are based on the PurchasedReferred Care Delivery Area (PRCDA) countiesHispanic is not mutually exclusive from whites blacks AsianPacific Islanders and American IndiansAlaska Natives Incidence data for Hispanics are based onNHIA and exclude cases from the Alaska Native Registry
Incidence MortalityRate per 100000 Rate per 100000
Year of Diagnosis Year of Death
a
d
a
b
c
c
b
d
SEE
R C
ancer Statistics Review
1975-2016N
ational Cancer Institute
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
0
20
40
60
80
100
120
1975 1980 1985 1990 1995 2000 2005 2010 2016
Male Delay-Adjusted IncidenceMale Delay-Adjusted Incidence
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence amp US Death Rates
1975-2016 All Races By Sex
Figure 155
Source SEER 9 areas and US Mortality Files (National Center for Health Statistics CDC)Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of DiagnosisDeath
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
0
20
40
60
80
100
120
140
160
180
1975 1980 1985 1990 1995 2000 2005 2010 2016
Black Male
White Male
Black Female
White Female
Cancer of the Lung amp BronchusSEER Delay-Adjusted Incidence 1975-2016
By Sex and Race
Figure 156
Source SEER 9 areas Rates are age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1103)Regression lines are calculated using the Joinpoint Regression Program Version 47 February 2019National Cancer Institute
Rate per 100000
Year of Diagnosis
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race
Graph - 5-Year SEER Conditional Relative Survival
Figure 157
Cancer of the Lung and Bronchus5-Year SEER Conditional Relative Survival and
95 Confidence Intervals
Source SEER 18 areas (San Francisco Connecticut Detroit Hawaii Iowa New Mexico Seattle Utah AtlantaSan Jose-Monterey Los Angeles Alaska Native Registry Rural Georgia California excluding SFSJMLAKentucky Louisiana New Jersey and Georgia excluding ATLRG)Percent surviving is not shown if based on less than 25 casesConfidence intervals are not shown if length of the confidence interval is greater than 5 times the standard error
0
20
40
60
80
100Percent Surviving Next 5 Years
Stage at Diagnosis
Probabilty of surviving the next 5 years given the cohort has already survived 0 1 or 3 years
2000-2015 by stage at diagnosis
Survival Time Since Diagnosis
Localized Regional Distant Unstaged
0 year (at diagnosis) 1 year 3 years
SEER Cancer Statistics Review 1975-2016 National Cancer Institute
Trends in SEER Incidence and US Mortality Both Sexes
Trends in SEER Incidence and US Mortality Males
Trends in SEER Incidence and US Mortality Females
Trends in SEER Incidence (Small Cell and Non-small Cell Cancer)
Annual Delay-adjusted Incidence Rates
Annual Incidence Rates
Annual Incidence Rates (Small Cell Cancer)
Annual Incidence Rates (Non-Small Cell Cancer)
Annual Death Rates
Incidence and Mortality Rates by Age
Incidence Rates by Age (Small Cell and Non-Small Cell Cancer)
5-year Relative and Period Survival
5-year Relative and Period Survival (Small Cell Cancer)
5-year Relative and Period Survival (Non-Small Cell Cancer)
Relative Survival by Year of Diagnosis Both Sexes
Relative Survival by Year of Diagnosis Males
Relative Survival by Year of Diagnosis Females
Risk of DevelopingDying Both Sexes
Risk of DevelopingDying Males
Risk of DevelopingDying Females
Rates and Trends by RaceEthnicity
Age-Adjusted SEER Incidence Rates by Registry
Age-Adjusted SEER Death Rates by Registry
Age-Adjusted Cancer Death Rates By State Both Sexes
Age-Adjusted Cancer Death Rates By State Males
Age-Adjusted Cancer Death Rates By State Females
US Prevalence Estimates
Case Distribution by Histology Both Sexes
Case Distribution by Histology Males
Case Distribution by Histology Females
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages lt65)
Graph - SEER Incidence Delay Adjusted Incidence and US Death Rates by Race and Sex (Ages 65+)
Graph - SEER Incidence and US Death Rates by RaceEthnicity
Graph - SEER Delay Adjusted Incidence and US Death Rates by Sex
Graph - SEER Delay Adjusted Incidence by Sex and Race